According to a CBS report on April 10, eight people in Georgia, the United States, experienced adverse reactions after being injected with Johnson & Johnson's new crown vaccine.
Oseltamivir treats flu, beware of this serious adverse reaction!
Time of Update: 2021-04-18
According to the App-Medication Query of the Doctor Station, the oseltamivir precautions column mentioned: flu patients (especially children and adolescents) who use this product have had reports of convulsions and delirium.
Chen Xiang/Han Leng/Liu Hong/Jing Ying collaborate to reveal gender-related differences in immune-related adverse reactions of cancer immunotherapy
Time of Update: 2021-04-18
/> This series of results will prompt the scientific research community to re-evaluate the impact of gender factors on immune-related adverse reactions, and also provide a research example for the study of clinical
Abbott's TriClip G4 tricuspid valve repair system obtains EU CE certification
Time of Update: 2021-04-18
CompilationFan DongdongA few days ago, Abbott's latest generation of upgraded minimally invasive transcatheter tricuspid valve repair system TriClip G4 has obtained CE mark approval from European regulatory agencies to help prevent blood leakage from the patient's heart tricuspid valve.
Haohaishengke: Injection molding and astigmatism intraocular lens products obtained EU CE certification
Time of Update: 2021-04-18
recently obtained the EU CE certification for foldable, hydrophobic acrylic, aspherical, and astigmatic intraocular lens products.
How common are local and systemic reactions to the mRNA new crown vaccine?
Time of Update: 2021-04-18
) to day 7, subjects need to answer questions about local and systemic reactions (such as pain at the injection site, fatigue, headache) and whether there are adverse health events (such as receiving medical care) ). Although
Huadong Medicine's polycaprolactone microsphere facial filler for injection obtained medical device registration certificate
Time of Update: 2021-04-17
Sinclair's medical device registration certificate, Ellansé®, is made of polycaprolactone microspheres (PCL) and carboxymethyl cellulose (CMC), and has the dual effects of "filling + repairing".
RET inhibitor TPX-0046 in the treatment of tumors, phase I/II SWORD-1 phase study has obtained preliminary clinical data
Time of Update: 2021-04-17
Among the 5 patients who did not undergo RET TKI, 4 showed tumor regression rates of -42%, -37%, -23%, and -3%.
Nuocheng Jianhua Obutinib Obtained NMPA Approval to Start Phase II Clinical Study for Treatment of Multiple Sclerosis
Time of Update: 2021-04-17
This is an international multi-center clinical phase II study evaluating the use of abutinib in patients with multiple sclerosis.
Individual vaccinators do not need to be overly anxious for psychogenic reactions
Time of Update: 2021-04-17
Why is it that in the process of vaccinating the new crown vaccine this time, it cannot be vaccinated with other vaccines, including HPV vaccine, under normal circumstances, Wang Huaqing said, mainly considering the identification of adverse reactions.
Scientists obtain a new generation of wheat germplasm that aggregates multiple excellent genes
Time of Update: 2021-04-17
Genetically modified CRISPR/Cas9 system-mediated multi-gene editing of wheat has obtained a new wheat germplasm that aggregates multiple excellent alleles.
Daily Heiqiao has successively obtained more than 100 million yuan of A+ and B rounds of financing, and is the first consumer product brand invested by iQiyi
Time of Update: 2021-04-16
36 Krypton learned that the new consumer brand "Daily Heiqiao" has recently received more than 100 million yuan in A+ and B rounds of financing.
Scientists obtain millet haploid for the first time
Time of Update: 2021-04-16
It lays a solid foundation for the establishment of a millet double-haploid sports breeding platform, which is of great significance to further increase the frequency of haploid induction and speed up the process of millet breeding.
Kangfang Bio-PD1 monoclonal antibody obtained FDA breakthrough therapy qualification for third-line treatment of metastatic nasopharyngeal carcinoma
Time of Update: 2021-04-14
